Cargando…

A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is a novel human coronavirus strain (HCoV) was initially reported in December 2019 in Wuhan City, China. This acute infection caused pneumonia-like symptoms and other respiratory tract illness. Its higher transmission and infecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anand, Nithishwer Mouroug, Liya, Devang Haresh, Pradhan, Arpit Kumar, Tayal, Nitish, Bansal, Abhinav, Donakonda, Sainitin, Jainarayanan, Ashwin Kumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971693/ https://www.ncbi.nlm.nih.gov/pubmed/33735271 http://dx.doi.org/10.1371/journal.pone.0248553

Ejemplares similares

Analysing non-synonymous mutations in XDR and MDR tuberculosis drugs
por: Surana, Pallavi, et al.
Publicado: (2019)

Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing
por: Luedemann, Max, et al.
Publicado: (2022)

Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells
por: Jainarayanan, Ashwin, et al.
Publicado: (2023)

Network Analysis Identifies Drug Targets and Small Molecules to Modulate Apoptosis Resistant Cancers
por: Fathima, Samreen, et al.
Publicado: (2021)

Virus-host interaction analysis in colorectal cancer identifies core virus network signature and small molecules
por: A.V.S, Sai Krishna, et al.
Publicado: (2022)

Unraveling unique and common cell type-specific mechanisms in glioblastoma multiforme
por: Fathima, Samreen, et al.
Publicado: (2021)

FGF2 Affects Parkinson’s Disease-Associated Molecular Networks Through Exosomal Rab8b/Rab31
por: Kumar, Rohit, et al.
Publicado: (2020)

Basic Fibroblast Growth Factor 2-Induced Proteome Changes Endorse Lewy Body Pathology in Hippocampal Neurons
por: Kumar, Rohit, et al.
Publicado: (2020)

New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells
por: Heinrich, Jörg C., et al.
Publicado: (2016)

Linear B-Cell Epitopes in Human Norovirus GII.4 Capsid Protein Elicit Blockade Antibodies
por: Moeini, Hassan, et al.
Publicado: (2021)

Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing
por: Krishnamoorthy, Pandikannan, et al.
Publicado: (2021)

Repurposing Pathogenic Variants of DMD Gene and its Isoforms for DMD Exon Skipping Intervention
por: Tyagi, Rahul, et al.
Publicado: (2019)

Repurposing of gastric cancer drugs against COVID-19
por: Sonkar, Charu, et al.
Publicado: (2021)

Identifying SARS-CoV-2 Entry Inhibitors through Drug Repurposing Screens of SARS-S and MERS-S Pseudotyped Particles
por: Chen, Catherine Z., et al.
Publicado: (2020)

Prolonged norovirus infections correlate to quasispecies evolution resulting in structural changes of surface-exposed epitopes
por: Afridi, Suliman Qadir, et al.
Publicado: (2021)

Potential Repurposed Drug Candidates for Tuberculosis Treatment: Progress and Update of Drugs Identified in Over a Decade
por: Sharma, Khushbu, et al.
Publicado: (2023)

Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using in vivo studies
por: Sharma, Mukta, et al.
Publicado: (2020)

The interplay between membrane topology and mechanical forces in regulating T cell receptor activity
por: Al-Aghbar, Mohammad Ameen, et al.
Publicado: (2022)

Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
por: Prasad, Kartikay, et al.
Publicado: (2021)

Novel repurposing of a Laerdal Airway trainer to simulate aerosolisation
por: Oman, Sven Peter, et al.
Publicado: (2021)

Repurposing Hepatitis C Direct-Acting Antivirals Against COVID-19
por: Kumar, Pramod, et al.
Publicado: (2021)

Computational guided approach for drug repurposing against SARS-CoV-2
por: Anand, Jigisha, et al.
Publicado: (2021)

Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing
por: Tomar, Prabhat Pratap Singh, et al.
Publicado: (2021)

Repurposing Screens of FDA-Approved Drugs Identify 29 Inhibitors of SARS-CoV-2
por: Ku, Keun Bon, et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-2 using computational approaches
por: Kumar, Sumit, et al.
Publicado: (2022)

Validation of Quantitative Ultrasonography for Osteoporosis Diagnosis in Postmenopausal Women Compared to Dual-Energy X-Ray Absorptiometry (DEXA)
por: Kushwaha, Narendra S, et al.
Publicado: (2023)

Hsp40 overexpression in pacemaker neurons delays circadian dysfunction in a Drosophila model of Huntington's disease
por: Prakash, Pavitra, et al.
Publicado: (2022)

Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection
por: Sahoo, Biswa Mohan, et al.
Publicado: (2021)

A comprehensive study on seroprevalence of bluetongue virus in Haryana state of India
por: Maan, Sushila, et al.
Publicado: (2017)

Computational methods directed towards drug repurposing for COVID-19: advantages and limitations
por: Sharma, Prem Prakash, et al.
Publicado: (2021)

Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing
por: Belyaeva, Anastasiya, et al.
Publicado: (2021)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment
por: Kumar, Raj, et al.
Publicado: (2021)

Computational guided drug repurposing for targeting 2′-O-ribose methyltransferase of SARS-CoV-2
por: Sharma, Kedar, et al.
Publicado: (2020)

Exploration of databases and methods supporting drug repurposing: a comprehensive survey
por: Tanoli, Ziaurrehman, et al.
Publicado: (2020)

Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2
por: Niranjan, Vidya, et al.
Publicado: (2022)

Potentially repurposable drugs for COVID-19 identified from SARS-CoV-2 Host Protein Interactome
por: Karunakaran, Kalyani B., et al.
Publicado: (2020)

Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19
por: Mirabelli, Carmen, et al.
Publicado: (2020)

Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19
por: Mirabelli, Carmen, et al.
Publicado: (2021)

A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors
por: Jo, Seri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8mpij40ivjj4o6h55rbpg26jv8